Who backs Indapta Therapeutics?
11 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Cancer Prevention and Research Institute of Texas | — |
| Leaps by Bayer | — |
| Leerink Partners | — |
| Lonza Group | — |
| Myeloma Investment Fund | — |
| National Cancer Institute | — |
| Pontifax Venture Capital | — |
| Red Cedar Ventures | — |
| Silicon Valley Bank | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Indapta Therapeutics investors
11 investors are on record for Indapta Therapeutics, including RA Capital Management, Cancer Prevention and Research Institute of Texas, Leaps by Bayer and Leerink Partners. The later-stage round in Sep 2025 drew 46 investors.
Free account
More of Indapta Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Indapta Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Indapta Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View